Gilead Sciences is donating its initial supply of the experimental treatment for COVID-19. The federal government is deciding where the scarce medicine goes, and there are questions about the choices.
Copyright 2020 NPR
Remdesivir Distribution Causes Confusion, Leaves Some Hospitals Empty-Handed
Facebook Twitter LinkedIn Email